Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. | 0 | reported | 05 May 2026 | tx 54+803,770−483,790 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | EXERCISE | Axsome Therapeutics, Inc. | 4,517 | 12.95 USD | 10b5-1 |
| 04 May 2026 | SALE | Axsome Therapeutics, Inc. | 4,517 | 227.94 USD | 10b5-1 |
| 05 May 2026 | EXERCISE | Axsome Therapeutics, Inc. | 233 | 12.95 USD | 10b5-1 |
| 05 May 2026 | SALE | Axsome Therapeutics, Inc. | 233 | 228.18 USD | 10b5-1anomaly |
| 04 May 2026 | EXERCISE | Axsome Therapeutics, Inc. | 4,517 | 0.00 USD | 10b5-1deriv |
| 05 May 2026 | EXERCISE | Axsome Therapeutics, Inc. | 233 | 0.00 USD | 10b5-1deriv |
| 21 Apr 2026 | GRANT_AWARD | Axsome Therapeutics, Inc. | 8,669 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Axsome Therapeutics, Inc. | 19,663 | 0.00 USD | deriv |
| 26 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 35,378 | 2.85 USD | |
| 26 Feb 2026 | SALE | Axsome Therapeutics, Inc. | 35,378 | 161.88 USD | |
| 26 Feb 2026 | EXERCISE | Axsome Therapeutics, Inc. | 35,378 | 0.00 USD | deriv |
| 22 Sept 2025 | SALE | Axsome Therapeutics, Inc. | 10,000 | 115.96 USD | |
| 22 Sept 2025 | EXERCISE | Axsome Therapeutics, Inc. | 10,000 | 2.85 USD | |
| 22 Sept 2025 | EXERCISE | Axsome Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 16 Sept 2025 | SALE | Axsome Therapeutics, Inc. | 5,783 | 116.19 USD | |
| 16 Sept 2025 | EXERCISE | Axsome Therapeutics, Inc. | 25,000 | 4.95 USD | |
| 16 Sept 2025 | EXERCISE | Axsome Therapeutics, Inc. | 15,000 | 4.85 USD | |
| 16 Sept 2025 | SALE | Axsome Therapeutics, Inc. | 40,000 | 114.23 USD | |
| 16 Sept 2025 | EXERCISE | Axsome Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 16 Sept 2025 | EXERCISE | Axsome Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 09 Jun 2025 | EXERCISE | Axsome Therapeutics, Inc. | 25,000 | 8.02 USD | |
| 09 Jun 2025 | SALE | Axsome Therapeutics, Inc. | 25,000 | 110.44 USD | |
| 09 Jun 2025 | EXERCISE | Axsome Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 28 May 2025 | SALE | Axsome Therapeutics, Inc. | 20,000 | 103.45 USD | |
| 28 May 2025 | EXERCISE | Axsome Therapeutics, Inc. | 20,000 | 6.47 USD |